Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Inventory (2020 - 2025)

Celularity (CELU) has disclosed Inventory for 6 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Inventory fell 35.33% to $2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.6 million, a 35.33% decrease, with the full-year FY2024 number at $5.4 million, down 5.98% from a year prior.
  • Inventory was $2.6 million for Q3 2025 at Celularity, down from $4.4 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $24.7 million in Q2 2022 to a low of $2.6 million in Q3 2025.
  • A 5-year average of $6.8 million and a median of $5.4 million in 2024 define the central range for Inventory.
  • Peak YoY movement for Inventory: plummeted 76.73% in 2023, then surged 67.44% in 2025.
  • Celularity's Inventory stood at $9.5 million in 2021, then plummeted by 44.41% to $5.3 million in 2022, then rose by 8.38% to $5.8 million in 2023, then dropped by 5.98% to $5.4 million in 2024, then plummeted by 52.62% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Inventory are $2.6 million (Q3 2025), $4.4 million (Q2 2025), and $6.2 million (Q1 2025).